Nabriva Therapeutics Plc OverviewNabriva Therapeutics Plc Other Income Expense Net
Other Income/Expense Net for NBRV.
Quarterly Other Income/Expense
-$225000.00
↓ 341.94% YoY
As of Mar 31, 2023
Annual Other Income/Expense (TTM)
-$445000.00
↓ 165.06% YoY
Trailing 12 months ending Mar 31, 2023